Faculty Scholarship

Center for Health & Pharmaceutical Law & Policy

Health and Pharmaceutical

Professor Kathleen Boozang, The Aspirations and Challenges of Decision Aids, Arizona Syllabus (Spring 2013)

Professor Kathleen Boozang, Annual Flora Barlotta Lecture: End of Life Care, (Spring 2011) (Saint Barnabas Medical Center)

Professor Carl Coleman, Attorneys as False Claims Act Whistleblowers: The Second Circuit Weighs In, REVUE INTERNATIONALE DE LA COMPLIANCE ET DE L'ETHIQUE DES AFFAIRES, no. 40, at 21 (October 2013)

Professor Kathleen Boozang, U.S. Waste Fraud and Abuse Laws, E.U. Corporate Compliance Program (June 2011) (Paris, France)

Professor Kate Greenwood, An Argument Against Embedding Conflicts of Interest Disclosures in Informed Consent, J. Health & Life Sci. L., 230-267 (June 2011) (with Kathleen M. Boozang and Carl H. Coleman)

Professor Carl Coleman, An Argument against Embedding Conflicts of Interest Disclosures in Informed Consent, J. Health & Life Sciences L., 230-267 (June 2011) (with Kathleen M. Boozang and Kate Greenwood)

Professor Kate Greenwood, The Alternate Approach to Medicinal Marijuana Distribution, The Record, O-1 (July 25, 2010)

Professor Carl Coleman, Improving the Quality of Host Country Ethical Oversight of International Research: The Use of a Collaborative ‘Pre-Review’ Mechanism for a Study of Fexinidazole for Human African Trypanosomiasis, DEVELOPING WORLD BIOETHICS (July 2014) (on behalf of the International Ethics Review Working Group)

Professor Carl Coleman, The Common Rule: US Regulatory Protections for Human Research Participants, International Encyclopedia of Social & Behavioral Sciences, 2d Ed. (forthcoming 2015)
View Professor Coleman's Bio

Professor Kate Greenwood, Medical Affairs: Effectively and Legitimately Using Medical Science Liaisons, Off-Label Communications: A Guide to Sales & Marketing Compliance (Food and Drug Law Institute 4th Ed. 2014) (with Deborah L. Shuff)
View Professor Greenwood's Bio

Professor Kate Greenwood, Toward Evidence-Based Conflicts of Interest Training for Physician-Investigators, J.L. Med. & Ethics, 500-507 (Fall 2012) (with Kathleen M. Boozang and Carl H. Coleman)

Professor Carl Coleman, International Issues, Fundamentals of Life Sciences Law: Drugs, Devices, and Biotech (American Health Lawyers Association, 2nd Ed., 2014) (with Simone Handler-Hutchinson)
View Professor Coleman's Bio

Professor Kate Greenwood, Physician Conflicts of Interest in Court: Beyond the "Independent Physician" Litigation Heuristic, 30 Ga. St. U. L. Rev. 759 (2014)

Professor John Jacobi, Medicaid Evolution for the 21st Century, __Kentucky L. J. __ (2013) (in press)

Professor Kathleen Boozang, Symposium: Is a For-Profit Structure a Viable Alternative for a Health Care Ministry?, Center for Religiously Affiliated Nonprofit Corporations & Center for Health & Pharmaceutical Law & Policy (2013) (In collaboration with University of St. Thomas)

Professor John Jacobi, New Jersey's Medicaid ACO Pilot Program, Past and Future: A Baseline Report, Seton Hall Center for Health & Pharmaceutical Law & Policy (2013) (co-authored with Tara Adams Ragone and Kate Greenwood)

Professor Carl Coleman, Toward Evidence-Based Conflict of Interest Compliance Training for Physician Investigators, 40 J.L. MED. & ETHICS 500 (2012) (with Kate Greenwood & Kathleen Boozang)

Professor Carl Coleman, End-of-Life Treatment Decisions in United States Law, Stefania Negri Ed., Self-Determination, Dignity and End-of-Life Care: Regulating Advance Directives in International and Comparative Perspecitve (2012)
View Professor Coleman's Bio

Professor John Jacobi, Active or Passive: The Role of a New Jersey Health Insurance Exchange, Rutgers Center for State Health Policy and Seton Hall Center for Health & Pharmaceutical Law & Policy (2012)

Professor Kathleen Boozang, The New Relator: In-House Counsel and Compliance Officers, J. H & Life Sciences L. (2012)

Professor John Jacobi, Implementing the Essential Health Benefits Requirement in New Jersey: Decision Points and Policy Issues, Rutgers Center for State Health Policy & Center for Health & Pharmaceutical Law & Policy (2012) (with Tara Ragone, Kate Greenwood and John Jacobi)

Professor Kathleen Boozang, Transparency: It May Not Be Sufficient, 4 Life Science Compliance 14 (2012)

Professor Kate Greenwood, Implementing the Essential Health Benefits Requirement in New Jersey: Decision Points and Policy Issues, policy brief issued by the Center for Health & Pharmaceutical Law & Policy & the Rutgers Center for State Health Policy (2012) (with John V. Jacobi and Tara Adams Ragone)

Professor Kate Greenwood, The Affordable Care Act’s Risk Adjustment and Other Risk-Spreading Mechanisms: Needed Support for New Jersey’s Health Insurance Exchange, policy brief issued by the Center for Health & Pharmaceutical Law & Policy and the Rutgers Center for State Health Policy (2012)

Professor Kate Greenwood, The Health Insurance Exchange, the Medicaid Program, and the Apportionment of Responsibility for Determining Eligibility and Effectuating Enrollment in New Jersey, policy brief issued by the Center for Health & Pharmaceutical Law & Policy and the Rutgers Center for State Health Policy (2012)

Professor Carl Coleman, The Role of Informed Consent in Turberculosis Testing and Screening, 39 European Respiratory J. 1057-59 (2012) (with Michael Selgelid, Andreas Reis, Lee Reichman, and Ernesto Jaramillo)

Professor John Jacobi, Health Insurance Exchanges: Governance Issues for New Jersey, Rutgers Center for State Health Policy and Seton Hall Center for Health & Pharmaceutical Law & Policy (2011)

Professor Kathleen Boozang, An Argument Against Embedding Conflicts of Interest Disclosures in Informed Consent, 4 J.H. & Life Sciences L. 230 (2011) (with Carl H. Coleman and Kate Greenwood)

Professor Kate Greenwood, The Ban on "Off-Label" Pharmaceutical Promotion: Constitutionally Permissible Prophylaxis against False or Misleading Commercial Speech?, 37 AM. J. L. & Med. 278 (2011) (symposium)

Professor John Jacobi, High Utilizers of ED Services: Lessons for System Reform, 20 Annals of Health Law 35 (2011)

Professor John Jacobi, Implementing Health Reform at the State Level: Access and Care for Vulnerable Populations, 39 J. Law, Medicine & Ethics 69 (2011) (with Watson and Restuccia)

Professor Carl Coleman, Do Physicians' Legal Duties to Patients Conflict with Public Health Values? The Case of Antibiotic Overprescription, Michael J. Selgelid et. al. eds., Infectious Disease Ethics: Limiting Liberty in Contexts of Contagion (2011)
View Professor Coleman's Bio

Professor Kate Greenwood, The Mysteries of Pregnancy: The Role of Law in Solving the Problem of Unknown but Knowable Maternal-Fetal Medication Risk, 79 U. Cin. L. Rev. 267 (2010)

Professor Kate Greenwood, The Limits of Disclosure as a Response to Financial Conflicts of Interest in Clinical Research, white paper issued by the Center for Health & Pharmaceutical Law & Policy (2010) (collaborator)

Professor Kate Greenwood, Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight, white paper issued by the Center for Health & Pharmaceutical Law & Policy (2009) (collaborator)

Professor Kate Greenwood, Drug and Device Promotion: Charting A Course for Policy Reform, white paper issued by the Center for Health & Pharmaceutical Law & Policy (2009) (collaborator)

Professor Carl Coleman, Do Physicians' Legal Duties Conflict with Public Health Values? The Case of Antibiotic Overprescription, 6 J. Bioethical Inquiry 181 (2009)

Professor John Jacobi, Prison Health, Public Health: Obligations and Opportunities, , 31 Am. J. Law & Medicine 447 (2005)

Professor John Jacobi, Quality Control, Enterprise Liability, and Disintermediation in Managed Care, 29 J. Law Medicine & Ethics 305 (2001) (with N. Huberfeld)